Harvard Bioscience (HBIO) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)

Harvard Bioscience (HBIO) Net Income towards Common Stockholders Growth (1y) (2011 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Income Growth (1y) (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn	23.94%
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn	-34.15%
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn	-
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn	0.98%
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn	-58.26%
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn	16.64%
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn	3.33%
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn	-188.83%
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn	38.46%
10	Harvard Bioscience	33.45 Mn	26.94 Mn	12.63 Mn	-27.41%

Download Data